News
-
Karuna Therapeutics soared 47.4% to $317.22 after Bristol Myers agreed to pay $330 per share, or $14 billion, to acquire the maker of the schizophrenia drug KarXT.
The U.S. Food and Drug Administration has accepted KarXT for a review.
Bristol-Myers declined 1.7% to $50.36.
Dec 22, 2023
Executive/
Director
Links
Price
- Last Close
-
$ 329.83
$ +0.09 0.03 %
Mar 15, 2024
- 52-Week High/Low
- $329.83 - $161.01
- YTD
- 0%
- Trading Volume
- 1,868,526
- Market Cap Full
- $ 12.4B
- Shares Outstanding
-
37.7M
Oct 31, 2023
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | - | - | - | - | -5% | 18.4% | -3.2% | -7.6% | 4.2% | - |
| Q2 | - | - | - | - | 4% | -5.2% | -0.2% | 19.4% | - | - |
| Q3 | - | - | - | -33.1% | 8% | 7.3% | 77.8% | -22% | - | - |
| Q4 | - | - | - | 349.7% | 31.4% | 7.1% | -12.6% | 94.7% | - | - |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | -1% | 0.2% | 5.1% | - | - | - | - | - | - | - | - | - |
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0% | 0% | 0% | 0% | 0% | 39% | 29% | 50% | 61% | 4% | 0% |
Earnings
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Q1 | - | - | - | - | - | -1.1 | -1.95 | -2.80 |
| Q2 | - | - | - | 146.02 | - | -1.17 | -2.17 | -2.75 |
| Q3 | - | - | - | 0.39 | - | -1.72 | -2.38 | -3.16 |
| Q4 | - | - | - | - | - | -0.95 | -2.24 | - |
| A | 0 | 0 | 0 | 146.4 | -2.6 | -4.9 | -8.7 | -8.71 |
Annual Returns
52 Week
High/Low
Annual
Earnings
Chart
Trading Volume
Outstanding Shares
(In Millions) +
Jan 16, 2024
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Mar | - | 26.1 | 27 | 29.8 | 34.5 |
| Jun | - | 26.1 | 29.5 | 29.9 | 37.4 |
| Sep | 23.4 | 26.6 | 29.6 | 30 | 37.7 |
| Dec | 23.4 | 26.8 | 29.6 | 34.4 | 37.7 |
SEC Filings
Financial Ratios
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Asset Management | |||||
| Inventory / Stock Turnover | - | - | - | - | - |
| Fixed Asset Turnover | 2.8 | 9.3 | - | - | - |
| Total Asset Turnover | - | 0.1 | - | - | - |
| Leverage | |||||
| Debt Ratio | - | - | - | - | - |
| Debt – Equity Ratio | - | - | - | - | - |
| Interest Coverage | 20.7 | - | 24 | 45 | -5 |
| Equity multiplier | - | - | - | - | - |